MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)
- Conditions
- ARDS
- Registration Number
- NCT04367077
- Lead Sponsor
- Healios K.K.
- Brief Summary
Multicenter investigation featuring an open-label lead-in followed by a double blinded, randomized, placebo-controlled Phase 2/3 part to evaluate the safety and efficacy of MultiStem therapy in subjects with moderate to severe Acute Respiratory Distress Syndrome (ARDS) due to pathogens including COVID-19.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 400
Diagnosis of new acute-onset moderate to severe ARDS, as defined by the Berlin criteria, requiring an endotracheal or tracheal tube, Evidence of pneumonia or severe localized or systemic infection
Moribund subject who, in the opinion of the Investigator, is not expected to survive at least 48 hours and End-stage severe chronic lung disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Primary Outcome Measures
Name Time Method Ventilator-Free Days Day 0 through Day 28. Safety and Tolerability as measured by the incidence of treatment-emergent adverse events as assessed by CTCAE v5.0. Day 28
- Secondary Outcome Measures
Name Time Method All-cause mortality Day 60 Ranked hierarchical composite outcome of alive and ventilator-free Day 28 Ventilator-free days Day 0 through Day 60
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (4)
Athersys Investigational Site 107
🇺🇸Chicago, Illinois, United States
Athersys Investigational Site 103
🇺🇸Akron, Ohio, United States
Athersys Investigational Site 101
🇺🇸Cleveland, Ohio, United States
Athersys Investigational Site 102
🇺🇸Cleveland, Ohio, United States
Athersys Investigational Site 107🇺🇸Chicago, Illinois, United StatesAthersys Clinical Trials GroupContact216-426-3597macovia@athersys.com